王建飛? 博士 南京艾美斐生物醫(yī)藥科技有限公司 首席科學(xué)官?
比較醫(yī)學(xué)高級(jí)醫(yī)師，國際AAALAC認(rèn)可委員會(huì)常務(wù)理事，中科院上海生命科學(xué)研究院教授（兼），上?？茖W(xué)院特聘教授。加拿大卡爾加里大學(xué)分子細(xì)胞學(xué)博士學(xué)位，在美國哈佛大學(xué)醫(yī)學(xué)院從事博士后研究。 曾任美國賓夕法尼亞大學(xué)比較醫(yī)學(xué)住院醫(yī)師4年，并獲執(zhí)醫(yī)資質(zhì)，任加拿大艾爾伯塔大學(xué)醫(yī)學(xué)院外科系教授。 曾擔(dān)任GSK中國研發(fā)中心整合生物技術(shù)科研部負(fù)責(zé)人，建立了完整的臨床前研發(fā)平臺(tái)，為公司的數(shù)十個(gè)項(xiàng)目提供靶點(diǎn)驗(yàn)證、先導(dǎo)化合物優(yōu)化、藥效學(xué)和藥代動(dòng)力學(xué)研究提供科學(xué)及技術(shù)支持，獲得GSK中國研發(fā)中心包括金獎(jiǎng)在內(nèi)的多次表彰，GSK全球整合生物平臺(tái)科研部領(lǐng)導(dǎo)之一, 并成功地推動(dòng)多個(gè)新藥研發(fā)項(xiàng)目完成臨床申報(bào)，進(jìn)入臨床試驗(yàn)，被評(píng)為高級(jí)GSK研究員（Senior GSK Fellow，公司科研最高級(jí)別學(xué)者）。在轉(zhuǎn)化醫(yī)學(xué)研究方面擁有超過28年的經(jīng)驗(yàn)，在世界著名的國際期刊上發(fā)表了70多篇論文，10多篇書刊章節(jié)，獲多項(xiàng)專利。
Dr. Jianfei Wang
Chief Scientific Officer (CSO), Member of the Board
Senior Physician in Comparative Medicine?
Professor of CAS Shanghai Institute of Biological Sciences (adjunct)
Honorary Head and Professor, Institute of Translational Medicine, Shanghai Academy of Sciences
Distinguished professor of Yunnan Agricultural University
Dr. Wang received a Ph.D. in Molecular Cell Biology from the University of Calgary, Canada and completed his residency in Comparative Medicine at the University of Pennsylvania, USA. He then pursued his postdoctoral research at Harvard Medical School. He was later appointed as a faculty member in the Department of Surgery at the Faculty of Medicine at the University of Alberta, Canada, before returning to China.
Dr. Wang is a seasoned executive with solid knowledge of both small and large molecule drugs and extensive experience in program insight for shaping R&D strategy. He has over 28 years of translational medicine research and team management experience in multinational pharmaceutical companies. At GSK R&D China, Dr. Wang established an integrated preclinical platform that provided support for target identification, validation, lead compound optimization, DMPK studies, discovery histopathology, safety assessment, and blood-brain barrier penetration for many projects that proceeded to candidate selections and clinical trials. Due to his distinguished contributions, Dr. Wang received many awards from GSK R&D China. He also served as a core member of the GSK global translational medicine leadership team and was elected as a Senior GSK Fellow, the highest level of scientific research scholar.
Dr. Wang’s contributions to translational medicine & drug discovery are recognized by being granted numerous distinguished awards, including an outstanding scientist by numerous national and international organizations. He has published more than 70 papers in prestigious international journals and owns multiple patents.